Literature DB >> 9453590

Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis.

T N Kirkland1, P W Thomas, F Finley, G T Cole.   

Abstract

The outcome of coccidioidomycosis depends to a large extent on the effectiveness of the T-cell-mediated immune (CMI) response to the fungal pathogen. For this reason, identification of Coccidioides immitis antigens which stimulate T cells is important for understanding the nature of host defense against the organism and essential for the development of an effective vaccine. Here we describe the immunogenicity of a 48-kDa T-cell-reactive protein (TCRP). The antigen is expressed by parasitic cells and localized in the cytoplasm. It stimulates the proliferative response and production of gamma interferon by T cells of mice immunized with C. immitis spherules. Specific antibody reactive with the recombinant TCRP (rTCRP) was detected in sera of patients with confirmed coccidioidal infection, and the highest titers of antibody to the recombinant protein correlated with elevated titers to the serodiagnostic complement fixation antigen of C. immitis. These results suggest that the TCRP is presented to the host during the course of infection. Immunization of BALB/c and C3H/HeN mice with the rTCRP affords a modest but significant level of protection against an intraperitoneal challenge with C. immitis. It is suggested that the rTCRP may be able to contribute to a multicomponent vaccine designed to stimulate CMI response against the parasitic cycle of C. immitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453590      PMCID: PMC107922     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  THE USE OF IMMUNODIFFUSION TESTS IN COCCIDIOIDOMYCOSIS. I. THE ACCURACY AND REPRODUCIBILITY OF THE IMMUNODIFFUSION TEST WHICH CORRELATES WITH COMPLEMENT FIXATION.

Authors:  M HUPPERT; J W BAILEY
Journal:  Tech Bull Regist Med Technol       Date:  1965-08

2.  An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis.

Authors:  G T Cole; T N Kirkland; S H Sun
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  Mechanisms of resistance to infection with Coccidioides immitis in mice.

Authors:  L V Beaman; D Pappagianis; E Benjamini
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

4.  Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.

Authors:  G Lecara; R A Cox; R B Simpson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Immunization of mice against coccidioidomycosis with a subcellular vaccine.

Authors:  D Pappagianis; R Hector; H B Levine; M S Collins
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

6.  Immunoreactivity of a surface wall fraction produced by spherules of Coccidioides immitis.

Authors:  G T Cole; T N Kirkland; M Franco; S Zhu; L Yuan; S H Sun; V M Hearn
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.

Authors:  D G Fish; N M Ampel; J N Galgiani; C L Dols; P C Kelly; C H Johnson; D Pappagianis; J E Edwards; R B Wasserman; R J Clark
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

8.  Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection.

Authors:  T N Kirkland; J Fierer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.

Authors:  D Pappagianis
Journal:  Am Rev Respir Dis       Date:  1993-09

10.  Isolation of antigens with proteolytic activity from Coccidioides immitis.

Authors:  G T Cole; S W Zhu; S C Pan; L Yuan; D Kruse; S H Sun
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

View more
  10 in total

1.  A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses.

Authors:  C Y Hung; N M Ampel; L Christian; K R Seshan; G T Cole
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.

Authors:  T N Kirkland; F Finley; K I Orsborn; J N Galgiani
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

3.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.

Authors:  K Li; J J Yu; C Y Hung; P F Lehmann; G T Cole
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.

Authors:  R O Abuodeh; L F Shubitz; E Siegel; S Snyder; T Peng; K I Orsborn; E Brummer; D A Stevens; J N Galgiani
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 6.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.

Authors:  Lisa F Shubitz; Sharon M Dial; Robert Perrill; Rachael Casement; John N Galgiani
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

Review 8.  Influence of host genetics on the severity of coccidioidomycosis.

Authors:  L Louie; S Ng; R Hajjeh; R Johnson; D Vugia; S B Werner; R Talbot; W Klitz
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

9.  Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.

Authors:  Kris I Orsborn; Lisa F Shubitz; Tao Peng; Ellen M Kellner; Marc J Orbach; Paul A Haynes; John N Galgiani
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  Biochemical characterization of an in-house Coccidioides antigen: perspectives for the immunodiagnosis of coccidioidomycosis.

Authors:  Renato Evando Moreira Filho; Silviane Praciano Bandeira; Raimunda Sâmia Nogueira Brillhante; Marcos Fábio Gadelha Rocha; Ilka Maria Vasconcelos; Mirella Leite Pereira; Débora de Souza Collares Maia Castelo-Branco; Francisco Airton Castro Rocha; Zoilo Pires de Camargo; Marcio Viana Ramos; Rossana de Aguiar Cordeiro; José Júlio Costa Sidrim
Journal:  Molecules       Date:  2012-06-28       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.